Journal of Neuroscience and Clinical Neurology

Masoumeh Khalili

PhD

  • Department: Behavioral Neuropharmacology
  • University: Fujita Health University
  • Country: Japan

Dr. Masoumeh Khalili is a Postdoctoral Researcher at the International Center for Brain Science, Fujita Health University, Toyoake, Japan. She obtained her Ph.D. in Pharmaceutical Sciences from Mazandaran University of Medical Sciences, Iran, where she conducted pioneering studies on the iron-chelating activity of medicinal plants and mushrooms, particularly Cantharellus cibarius. Before joining Fujita Health University, Dr. Khalili served as a Researcher and Vice Chancellor at the Neuroscience Research Center of Golestan University of Medical Sciences in Iran. During this period, she led multiple research projects investigating the antioxidant and neuroprotective properties of natural compounds and their potential therapeutic roles in neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. Currently, at Fujita Health University, her research focuses on Fetal Alcohol Spectrum Disorders (FASD), studying both molecular and behavioral consequences of prenatal alcohol exposure, as well as transgenic and knockout mouse models related to bipolar disorder mechanisms.

  • Postdoctoral Researcher – Division of Behavioral Neuropharmacology, International Center for Brain Science, Fujita Health University (Japan, 2024–Present)

  • Researcher & Vice Chancellor – Neuroscience Research Center, Golestan University of Medical Sciences (Iran, 2016–2024)

  • Graduate Research Assistant – Mazandaran University of Medical Sciences (Iran, 2011–2015)

  • Supervisor – Ethical Animal Studies Project funded by Iran’s Ministry of Health and Medical Education

  • Active Member – Animal Ethics Committee, Golestan University of Medical Sciences

  • Reviewer for numerous international journals, including:

    • European Journal of Pharmacology

    • Cellular Physiology and Biochemistry

    • Natural Product Research

    • Computers in Biology and Medicine

    • Current Medicinal Chemistry

    • International Journal of Peptide Research and Therapeutics

  • Corrigendum to: 6-OHDA mediated neurotoxicity in SH-SY5Y cellular model of Parkinson disease suppressed by pretreatment with hesperidin through activating L-type calcium channels
  • Vanillin serves as a potential substitute for chemical chelator desferal in iron-overloaded mice
  • Vanillin serves as a potential substitute for chemical chelator desferal in iron-overloaded mice
  • Naringin prevents the reduction of the number of neurons and the volume of CA1 in a Scopolamine-Induced animal model of Alzheimer's disease (AD): A stereological study
  • Naringin is a promising natural compound for therapy of iron-overload disorders
  • Reduction of iron toxicity in the heart of iron-overloaded mice with natural compounds
  • Berberine Is a Promising Alkaloid to Attenuate Iron Toxicity Efficiently in Iron-Overloaded Mice
  • Comparison Between Hesperidin, Coumarin, and Deferoxamine Iron Chelation and Antioxidant Activity Against Excessive Iron in the Iron Overloaded Mice
  • Naringin Chelates Excessive Iron and Prevents the Formation of Amyloid-Beta Plaques in the Hippocampus of Iron-Overloaded Mice
  • Searching For Vitamin C, Vitamin D and COVID-19: a Google Trends Study